TGTX
#985
TG Therapeutics, Inc. - Common Stock
54.3 7 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.06%
Changement Mensuel
+2.35%
Evolution sur 6 mois
+57.32%
Changement Annuel
+55.65%
Clôture Précédente
54.3 4
Open
54.0 8
Low
53.3 6
High
55.3 7
Financials
- Market Capitalization 8.32 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
10.76
ratio cours/chiffre d'affaires
7.81
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 953 |  CYTK Cytokinetics, Incorporated - Common Stock | 63.43 USD | +2.94% | +5.17% | -8.76% | +9.17% | 8.82 B USD | ||
| 971 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 162.22 USD | +3.77% | -4.63% | -20.75% | +24.59% | 8.50 B USD | ||
| 988 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 58.37 USD | +0.41% | -3.58% | -17.10% | +49.28% | 8.25 B USD | ||
| 1063 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 42.70 USD | +0.76% | -2.44% | -9.53% | -40.80% | 7.10 B USD |